Autopsy report · NCT04625426

Evaluation of Skin Cleansers and Skin Protectants in Management of Incontinence-associated Dermatitis

“Early termination due to COVID-19 pandemic led to inability to reach planned sample size”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 5 months after it had already started.
• Ran for about 1 year 5 months before it stopped.
• 86 participants enrolled.
• Results were posted on the registry 7 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Tan Tock Seng Hospital

Sponsor type

University, hospital or other

Conditions

Incontinence-associated Dermatitis

Interventions

3M Cavilon No-Rinse Skin Cleanser and 3M Cavilon Advanced Skin Protectant; Conveen EasiCleanse and Conveen Critic Barrier; Standard cleansing and Conveen Critic Barrier

Participants

86

Sites

1

Countries

Singapore

Trials that died the same way

• Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
  “Recruitment was stopped before the planned sample size was reached owing to the Covid-19 pandemic and expiration of funding.” (76% match in meaning)
• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis
  “The study was terminated prematurely due to the COVID-19 pandemic creating uncertainty impacting trial progress and costs.” (75% match in meaning)
• OptiVol for Precision Medical Management of Heart Failure
  “Early termination due to COVID Pandemic” (75% match in meaning)
• Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study
  “Early termination related to COVID pandemic” (73% match in meaning)
• A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
  “Termination due to challenges related to the operational feasibility of the study, taking into account the current epidemiology and declining hospitalization rates for severe COVID-19.” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.